4.5 Article

Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive

Related references

Note: Only part of the references are listed.
Article Surgery

The Fourth International Workshop on Clinical Transplant Tolerance

Fadi Issa et al.

Summary: The International Workshop on Clinical Transplant Tolerance focuses on the progress of studies involving immunosuppression minimization or withdrawal in solid organ transplantation. The latest workshop showcased clinical trials utilizing donor or recipient cell therapy in combination with organ transplantation to minimize or withdraw immunosuppressive drugs. Additionally, mechanisms of tolerance and potential predictors/biomarkers were discussed, as well as strategies to enhance safety and improve patient selection/risk stratification for clinical trials in hematopoietic cell transplantation.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Surgery

Cellular therapies in organ transplantation

Martin J. Hoogduijn et al.

Summary: Cellular therapy shows promise in improving organ transplantation outcomes by utilizing different cell types with immunoregulatory and regenerative properties. Advancements in preclinical models and early clinical trials have demonstrated both feasibility and safety, paving the way for efficacy studies in humans. Monitoring tools and endpoints for these studies are crucial for further development.

TRANSPLANT INTERNATIONAL (2021)

Article Surgery

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients

Paul N. Harden et al.

Summary: Using autologous polyclonal regulatory T cell therapy in kidney transplantation can reduce immunosuppression dosage, leading to improved long-term clinical outcomes with potentially lower rejection rates compared to standard immunosuppression.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Immunology

Immune Monitoring for Advanced Cell Therapy Trials in Transplantation: Which Assays and When?

Helen L. Stark et al.

Summary: Immune regulatory cellular therapies, such as regulatory T cells and mesenchymal stromal cells, are being explored as alternative treatments for transplant alloresponses. Advanced immune monitoring strategies are necessary to understand the impact of these therapies in vivo, requiring a combination of methods to measure cellular phenotypes, molecular profiles, and cell functions accurately.

FRONTIERS IN IMMUNOLOGY (2021)

Article Surgery

Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation

Alberto Sanchez-Fueyo et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Biotechnology & Applied Microbiology

Spatiotemporal PET Imaging Reveals Differences in CAR-T Tumor Retention in Triple-Negative Breast Cancer Models

Alessia Volpe et al.

MOLECULAR THERAPY (2020)

Article Cell Biology

Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells

Nicholas A. J. Dawson et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Immunology

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Review Immunology

Regulatory T cells for tolerance

Kento Kawai et al.

HUMAN IMMUNOLOGY (2018)

Article Immunology

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Jason D. Fontenot et al.

JOURNAL OF IMMUNOLOGY (2017)

Article Medicine, Research & Experimental

Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor

Katherine G. MacDonald et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Biotechnology & Applied Microbiology

Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases

Mark J. Osborn et al.

MOLECULAR THERAPY (2016)

Review Oncology

The paradoxical role of IL-10 in immunity and cancer

Mark H. Mannino et al.

CANCER LETTERS (2015)

Article Cell Biology

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

Jeffrey A. Bluestone et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Urology & Nephrology

Comparison of Regulatory T Cells in Hemodialysis Patients and Healthy Controls: Implications for Cell Therapy in Transplantation

Behdad Afzali et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)

Article Biochemistry & Molecular Biology

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals

C. Arber et al.

GENE THERAPY (2013)

Article Endocrinology & Metabolism

Administration of CD4+CD25highCD127- Regulatory T Cells Preserves β-Cell Function in Type 1 Diabetes in Children

Natalia Marek-Trzonkowska et al.

DIABETES CARE (2012)

Review Immunology

Human FoxP3+ regulatory T cells in systemic autoimmune diseases

Makoto Miyara et al.

AUTOIMMUNITY REVIEWS (2011)

Review Immunology

The regulation of IL-10 production by immune cells

Margarida Saraiva et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Review Immunology

The promise and potential pitfalls of chimeric antigen receptors

Michel Sadelain et al.

CURRENT OPINION IN IMMUNOLOGY (2009)

Article Immunology

Dynamics of peripheral tolerance and immune regulation mediated by Treg

Shimon Sakaguchi et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2009)

Article Biotechnology & Applied Microbiology

Optimized production and concentration of lentiviral vectors containing large inserts

Nadya Al Yacoub et al.

JOURNAL OF GENE MEDICINE (2007)

Article Immunology

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

JD Fontenot et al.

NATURE IMMUNOLOGY (2003)

Article Biotechnology & Applied Microbiology

Systematic determination of the packaging limit of lentiviral vectors

M Kumar et al.

HUMAN GENE THERAPY (2001)